Yoko Kubuki

3.0k total citations
34 papers, 628 citations indexed

About

Yoko Kubuki is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Yoko Kubuki has authored 34 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Yoko Kubuki's work include T-cell and Retrovirus Studies (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Vector-Borne Animal Diseases (10 papers). Yoko Kubuki is often cited by papers focused on T-cell and Retrovirus Studies (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Vector-Borne Animal Diseases (10 papers). Yoko Kubuki collaborates with scholars based in Japan, South Korea and Serbia. Yoko Kubuki's co-authors include Kazuya Shimoda, Takuro Kameda, Kotaro Shide, Tomonori Hidaka, Akihiko Okayama, Haruko Shimoda, Kenji Nagata, Satoru Hasuike, Tadashi Matsuda and Masaaki Sekine and has published in prestigious journals such as Blood, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yoko Kubuki

33 papers receiving 618 citations

Peers

Countries citing papers authored by Yoko Kubuki

Since Specialization

Citations

This map shows the geographic impact of Yoko Kubuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Kubuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Kubuki more than expected).

Fields of papers citing papers by Yoko Kubuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Kubuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Kubuki. The network helps show where Yoko Kubuki may publish in the future.

Co-authorship network of co-authors of Yoko Kubuki

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Kubuki. A scholar is included among the top collaborators of Yoko Kubuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Kubuki. Yoko Kubuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms 2020 ·Blood ·Kotaro Shide, Takuro Kameda, Ayako Kamiunten, (unknown), Yuki Tahira, Takako Yokomizo‐Nakano, Sho Kubota, Masaya Ono, Kazuhiko Ikeda, Masaaki Sekine, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Goro Sashida, Kazuya Shimoda	10
2	Clinical characteristics of adult T-cell leukemia/lymphoma infiltration in the gastrointestinal tract 2020 ·BMC Gastroenterology ·Tadashi Miike, Hiroshi Kawakami, Takuro Kameda, Shojiro Yamamoto, Yoshihiro Tahara, Tomonori Hidaka, Yoko Kubuki, Kenji Yorita, Yutaka Akiyama, Yasuji Arimura, Yoshimasa Kubota, Hiroaki Kataoka, Kazuya Shimoda	2
3	CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ 2020 ·Blood ·Takuro Kameda, Kotaro Shide, Ayako Kamiunten, Yuki Tahira, Masaaki Sekine, Keiichi Akizuki, Tomonori Hidaka, Yoko Kubuki, (unknown), Daisuke Morishita, Kazuya Shimoda	2
4	TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia 2020 ·BMC Cancer ·Keiichi Akizuki, Masaaki Sekine, Yasunori Kogure, Takuro Kameda, Kotaro Shide, Junji Koya, Ayako Kamiunten, Yoko Kubuki, Yuki Tahira, Tomonori Hidaka, (unknown), Hiroyuki Tanaka, Yuichiro Sato, Hiroaki Kataoka, Keisuke Kataoka, Kazuya Shimoda	17
5	Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice 2020 ·Leukemia ·(unknown), Kotaro Shide, Takuro Kameda, Ayako Kamiunten, Yuki Tahira, Masaaki Sekine, Keiichi Akizuki, Kenichi Nakamura, Hisayoshi Iwakiri, (unknown), Tomonori Hidaka, Yoko Kubuki, Shojiro Yamamoto, Satoru Hasuike, Akira Sawaguchi, Kenji Nagata, Kazuya Shimoda	29
6	Non-canonical Expression of Cardiac Troponin-T in Neuroendocrine Ethmoid Sinus Carcinoma Following Immune Checkpoint Blockade 2019 ·Frontiers in Cardiovascular Medicine ·Toshihiro Tsuruda, Yuichiro Sato, (unknown), (unknown), Yoko Kubuki, (unknown), Masao Kikuchi, Tetsunori Ishikawa, Tetsuya Tono, Kazuo Kitamura	4
7	Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm 2017 ·Anticancer Research ·(unknown), Kotaro Shide, Takuro Kameda, Masaaki Sekine, Ayako Kamiunten, Tomonori Hidaka, Yoko Kubuki, Haruko Shimoda, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, (unknown), Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Kazuya Shimoda	1
8	Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma 2017 ·Biochemical and Biophysical Research Communications ·(unknown), Shingo Nakahata, Tomonaga Ichikawa, Akira Kitanaka, Takuro Kameda, Tomonori Hidaka, Yoko Kubuki, Gene Kurosawa, Lilin Zhang, Yukio SUDO, Kazuya Shimoda, Kazuhiro Morishita	30
9	Mogamulizumab for ATLL in Clinical Practice 2016 ·Blood ·Masaaki Sekine, Masaki Takeuchi, (unknown), (unknown), Seiichi Sato, Kiyoshi Yamashita, (unknown), Keiichi Akizuki, Ayako Kamiunten, Takuro Kameda, Kotaro Shide, Tomonori Hidaka, Yoko Kubuki, Akira Kitanaka, Kazuya Shimoda	1
10	Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms 2015 ·Genomics Data ·Takuro Kameda, Kotaro Shide, (unknown), Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Goro Sashida, Kazumasa Aoyama, Makoto Yoshimitsu, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Atsushi Iwama, Akira Kitanaka, Kazuya Shimoda	3
11	TET2 Mutation in Adult T-Cell Leukemia/Lymphoma 2015 ·Journal of Clinical and Experimental Hematopathology ·Kazuya Shimoda, Kotaro Shide, Takuro Kameda, Tomonori Hidaka, Yoko Kubuki, Ayako Kamiunten, Masaaki Sekine, Keiichi Akizuki, Haruko Shimoda, (unknown), Kenichi Nakamura, (unknown), Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, (unknown), Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Akira Kitanaka	16
12	Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma 2012 ·Leukemia ·Shingo Nakahata, Yusuke Saito, Kousuke Marutsuka, Tomonori Hidaka, Koichi Maeda, Kinta Hatakeyama, Toshiyuki Shiraga, Akiteru Goto, Naofumi Takamatsu, Yujiro Asada, Atae Utsunomiya, Akira Okayama, Yoko Kubuki, Kazuya Shimoda, Yoshinori Ukai, Gene Kurosawa, Kazuhiro Morishita	39
13	TET2 is essential for survival and hematopoietic stem cell homeostasis 2012 ·Leukemia ·Kotaro Shide, Takuro Kameda, Haruko Shimoda, (unknown), (unknown), Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, (unknown), Yoko Kubuki, Shojiro Yamamoto, Tadashi Miike, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Kousuke Marutsuka, Atsushi Iwama, Tadashi Matsuda, Akira Kitanaka, Kazuya Shimoda	64
14	Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma 2010 ·International Journal of Hematology ·Takuro Kameda, Kotaro Shide, Haruko Shimoda, Tomonori Hidaka, Yoko Kubuki, (unknown), Yuko Taniguchi, Masaaki Sekine, (unknown), (unknown), Kenji Nagata, Takuya Matsunaga, Kazuya Shimoda	10
15	Activation of complement system in adult T-cell leukemia (ATL) occurs mainly through lectin pathway: A serum proteomic approach using mass spectrometry 2008 ·Cancer Letters ·Yoichi Ishida, Kiyoshi Yamashita, Hidenori Sasaki, (unknown), Yoko Kubuki, Kazuhiro Morishita, Hirohito Tsubouchi, Akihiko Okayama	23
16	Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F 2007 ·Leukemia ·Kotaro Shide, Haruko Shimoda, (unknown), Kennosuke Karube, Takuro Kameda, K Takenaka, S. Oku, (unknown), (unknown), Yoko Kubuki, Kazunori Kusumoto, Satoru Hasuike, Yoshihiro Tahara, Kenji Nagata, Tadashi Matsuda, Koichi Ohshima, M Harada, Kazuya Shimoda	133
17	Engraftment of peripheral blood mononuclear cells from human T‐lymphotropic virus Type 1 carriers in NOD/SCID/γc^null (NOG) mice 2007 ·International Journal of Cancer ·Ichiro Takajo, Kazumi Umeki, Kazuhiro Morishita, Ikuo Yamamoto, Yoko Kubuki, Kinta Hatakeyama, Hiroaki Kataoka, Akihiko Okayama	22
18	Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma 2005 ·Oncology Reports ·(unknown), Akio Ido, (unknown), (unknown), Kiyoshi Yamashita, Yoko Kubuki, (unknown), Hitoshi Matsuoka, Hirohito Tsubouchi	4
19	Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia 2004 ·Leukemia & lymphoma ·Yoko Kubuki, (unknown), Hidenori Sasaki, (unknown), Kiyoshi Yamashita, Koichi Maeda, Akio Ido, Hitoshi Matsuoka, Akihiko Okayama, Toshio Nakanishi, Hirohito Tsubouchi	47
20	Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γc^nullMice: Suppression by an Inhibitor against NF-κB 2003 ·Journal of Virology ·Md. Zahidunnabi Dewan, Kazuo Terashima, Midori Taruishi, Hideki Hasegawa, Mamoru Ito, Yuetsu Tanaka, Naoki Mori, Tetsutaro Sata, Yoshio Koyanagi, Michiyuki Maeda, Yoko Kubuki, Akihiko Okayama, Masahiro Fujii, Naoki Yamamoto	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact